These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan. Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426 [TBL] [Abstract][Full Text] [Related]
6. Protein glycosylation in disease: new insights into the congenital muscular dystrophies. Martin-Rendon E; Blake DJ Trends Pharmacol Sci; 2003 Apr; 24(4):178-83. PubMed ID: 12707004 [TBL] [Abstract][Full Text] [Related]
7. Dystroglycan glycosylation and its role in matrix binding in skeletal muscle. Martin PT Glycobiology; 2003 Aug; 13(8):55R-66R. PubMed ID: 12736199 [TBL] [Abstract][Full Text] [Related]
8. Increased levels of expression of dystroglycan may protect the heart. Brancaccio A Neuromuscul Disord; 2013 Nov; 23(11):867-70. PubMed ID: 23911074 [TBL] [Abstract][Full Text] [Related]
9. [Dystroglycan linkage and muscular dystrophy]. Shimizu T Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674 [TBL] [Abstract][Full Text] [Related]
10. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029 [TBL] [Abstract][Full Text] [Related]